Glow Lifetech Grants Stock Options

Rhea-AI Summary

Glow Lifetech Corp. (CSE: GLOW, OTC Pink: GLWLF) has announced the granting of 3,050,000 stock options to various company stakeholders, including directors, officers, employees, and consultants. The options are exercisable at $0.06 per common share over a five-year period from the grant date. Of the total options, 2,400,000 were granted to company insiders. The options and any resulting common shares are subject to a four-month and one-day resale restriction. The company utilized exemptions from MI 61-101 requirements regarding valuation and minority shareholder approval for the insider participation in this option grant.

Positive

• Stock options align management and employee interests with shareholders
• Long-term exercise period of 5 years provides retention incentive

Negative

• Potential dilution of 3,050,000 shares if all options are exercised
• 78.7% of options granted to insiders may raise corporate governance concerns

Toronto, Ontario--(Newsfile Corp. - June 13, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has granted 3,050,000 stock options (the "Options") to various directors, officers, employees and consultants of the Company. Each Option is exercisable at a price of $0.06 for one common share of the Company (each a "Common Share") for a period of five years from the date of grant and are being issued under the terms of the Company's Omnibus Long-Term Incentive Plan. The Options, and any Common Shares issued upon exercise of the Options, are subject to a four-month and one day resale restriction from the date of grant.

The aforementioned grant of Options resulted in certain insiders of the Company receiving an aggregate of 2,400,000 Stock Options. The Company has relied on the exemptions from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), contained in section 5.5(b) and 5.7(a) of MI 61-101 in respect of such insider participation.

SUBSCRIBE: For more information on Glow or to subscribe to the Company's mail list visit: https://www.glowlifetech.com/news.

About Glow Lifetech Corp

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

Website: www.glowlifetech.com

Contact:
Rob Carducci, CEO
Glow Lifetech Corp.
TF. 855-442-GLOW (4569)
ir@glowlifetech.com

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255546

FAQ

How many stock options did Glow Lifetech (GLWLF) grant in June 2025?

Glow Lifetech granted 3,050,000 stock options, with 2,400,000 of these options going to company insiders.

What is the exercise price of Glow Lifetech's June 2025 stock options?

The stock options have an exercise price of $0.06 per common share.

What is the vesting period for Glow Lifetech's 2025 stock options?

The options have a four-month and one-day resale restriction from the date of grant and are exercisable for a period of five years.

How many insiders received stock options in Glow Lifetech's June 2025 grant?

Company insiders received an aggregate of 2,400,000 stock options out of the total 3,050,000 options granted.